List of findings

Use the filters on the left to narrow down the list of findings, or use "Browse by keyword" on the right to locate a specific finding.

Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching…
As intensive methamphetamine use has increased in both Australia and New Zealand, associated health harms have also increased.In Australia, hospitalizations and the number of people in drug-related treatment related to methamphetamine use have increased over the long-term, although recent data…
Methamphetamine-related harms show mixed trends across North America.In Mexico, methamphetamine harms have increased in recent years, reflected in a growing number of people entering drug-related treatment for the substance – though recent data suggest possible signs of stabilization.In contrast,…
Following a major upward trend over the last two decades, methamphetamine seizures in North America declined over the 2021-2024 period. In parallel to declines in the quantities of methamphetamine seized in recent years, there have been ongoing declines…
Seizures of methamphetamine have shown a clear upward trend in Oceania over the last decade. Seizures of methamphetamine in Oceania reached a new record high in 2024, mainly driven by rising seizures reported from Australia and New Zealand. At the same time, the…
In Australia, past-year methamphetamine use has declined since 2004, but among people who still used the drug, there are signs of increases in intensive use patterns.A similar trend is observed in New Zealand, where the police characterize the methamphetamine market as saturated. Intensive use of…